CompaniesCatalytica Pharmaceuticals

Catalytica Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

20

By Phase

PHASE2: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
Today
NCT03541447
Hover over trial bars to see details

Recent Trials

NCT03541447Collaborator
Tolvaptan-Octreotide LAR Combination in ADPKD
PHASE2Completed
20 participants
Started: Dec 12, 2018 · Completed: Dec 23, 2021
Related Companies
Dsm----------------------------------------if You Believe Any Of This Information Is Incorrect
acquired